Yaşlı bir erkekte prostat biyopsisi sonrası gelişen zor ve nadir iki komplikasyon

Öz

Prostat kanseri erkeklerde ikinci sıklıkta görülen kanser tipi olmasına rağmen mortalite hızı düşüktür. Avrupa Randomize Prostat Kanser Tarama çalışmasında; prostat spesifik antijen ile taramada 13 yıllık takipte mortalitede belirgin düşüş sağlanmasına rağmen fayda ve zararları arasındaki belirsiz denge nedeniyle prostat spesifik antijen ile genel toplum taraması önerilmemiştir. Vakamızda; üriner semptomlar nedeniyle prostat biyopsisi yapıldıktan sonra enfektif endokardit ve spondilodiskit gelişti ve bu komplikasyonlara yönelik iki ciddi operasyon planlandı, uzun ve ciddi bir antibiyoterapi süreci ile antibiyoterapiye bağlı yan etkiler ortaya çıktı. Bu vaka ışığında, klinisyenlerin asemptomatik erkeklerde tarama yaparken veya prostat biyopsisi kararı verirken bu komplikasyonları göz önünde bulundurmaları önerilir.

Anahtar Kelimeler

• Yaşlı hasta,Prostat kanseri,İnfektif endokardit

Rare and challenging two complications after prostate biopsy of an older man

Abstract

Although prostate cancer is the second most common cancer type in men, its mortality rate is lower. Despite European Randomized Study of Screening for Prostate Cancer study reported that screening with prostate-specific antigen made a substantial reduction in prostate cancer mortality at 13 years of follow-up; they do not recommend population screening with prostate specific antigen because of the uncertain balance between benefits and harms. In our case, prostate biopsy was performed because of urinary symptoms but two severe operation planned due to infective endocarditis and spondylitis, a long and serious antibiotherapy process and its side effects were occurred after prostate biopsy. In light of this case, clinicians should consider that prostate biopsy may cause serious complications when they are screening asymptomatic men for prostate cancer or deciding whether or not to have a prostate biopsy.

Keywords

• Older patient,Prostate cancer,Infective endocarditis

References

1. 1. Center MM, Jemal A, Lortet-Tieulent J, Ward E, Ferlay J, Brawley O, et al. International variation in prostate cancer incidence and mortality rates. European Urology. 2012;61(6):1079-92.
2. 2. Schroder FH, Hugosson J, Roobol MJ, Tammela TL, Zappa M, Nelen V, et al. Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up. Lancet. 2014;384(9959):2027-35. doi: 10.1016/S0140-6736(14)60525-0. PMID: 25108889; PMCID: PMC4427906.
3. 3. Carter HB, Albertsen PC, Barry MJ, Etzioni R, Freedland SJ, Greene KL, et al. Early detection of prostate cancer: AUA Guideline. The Journal of Urology. 2013;190(2):419-26.
4. 4. Parker C, Gillessen S, Heidenreich A, Horwich A. Cancer of the prostate: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals of Oncology. 2015;26(suppl 5):v69-v77.
5. 5. Bonow RO, Carabello BA, Chatterjee K, de Leon AC, Faxon DP, Freed MD, et al. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing Committee to Revise the 1998 guidelines for the management of patients with valvular heart disease) developed in collaboration with the Society of Cardiovascular Anesthesiologists endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. Journal of the American College of Cardiology. 2006;48(3):e1-e148.
6. 6. Antman EM, Hand M, Armstrong PW, Bates ER, Green LA, Halasyamani LK, et al. 2007 Focused Update of the ACC/AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines: developed in collaboration With the Canadian Cardiovascular Society endorsed by the American Academy of Family Physicians: 2007 Writing Group to Review New Evidence and Update the ACC/AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction, Writing on Behalf of the 2004 Writing Committee. Circulation. 2008;117(2):296-329. doi: 10.1161/CIRCULATIONAHA.107.188209. PMID: 18071078.
7. 7. Habib G, Lancellotti P, Antunes MJ, Bongiorni MG, Casalta J-P, Del Zotti F, et al. 2015 ESC Guidelines for the management of infective endocarditis. European Heart Journal. 2015:ehv319.
8. 8. Hiyama Y, Takahashi S, Uehara T, Ichihara K, Hashimoto J, Masumori N. A case of infective endocarditis and pyogenic spondylitis after transrectal ultrasound guided prostate biopsy. J Infect Chemother. 2016;22(11):767-9. Epub 2016/10/26. doi: 10.1016/j.jiac.2016.05.002. PMID: 27374863.